Join Dr. Lewis S. Nelson, Chair of the Department of Emergency Medicine and Director of the Division of Medical Toxicology at Rutgers New Jersey Medical School, as he explains the clinical and regulatory aspects of urine toxicology testing, including screening versus confirmatory testing, genesis of false positive and false negative drug test results, interpretation of test results in a clinical context, and approaching the patient with their test results.
Continuing Education Credits
NAATP is a NAADAC approved education provider #64394. This webinar qualifies for 1 credit hour. NAADAC approved CE(s) are accepted by most state licensing and certification boards. Please contact your credentialing board or visit NAADAC’s website for CE acceptance information.
- Describe two circumstances in which urine drug testing is likely worthwhile
- Explain why false positive and false negative drug test results occur
- Discuss two approaches to responding to patients about positive test results
Lewis S. Nelson, MD, is Professor and Chair of the Department of Emergency Medicine and Director of the Division of Medical Toxicology at Rutgers New Jersey Medical School, all in Newark, NJ. He is a Senior Consultant to the New Jersey Poison Information & Education System. He is board certified in emergency medicine, medical toxicology, and addiction medicine. His areas of specific interest include preventing and managing the consequences of opioid use, multimodal pain management strategies, medication for addiction treatment in the ED, and health policy focused on medication safety and clinical quality.